Zyla Life Sciences Lessee, Operating Lease, Liability, to be Paid, Year Two
Zyla Life Sciences had Lessee, Operating Lease, Liability, to be Paid, Year Two of $1.23 million as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo · last filed 2020-05-14
- 2020-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $1.23M.
- 2019-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $1.23M.
- 2019-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Two $1.27M.
- 2019-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Two $809.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Two |
|---|---|
| 2020-03-31 | $1.23M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $1.23M 10-K · filed 2020-03-26 |
| 2019-09-30 | $1.27M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $809.00K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $809.00K 10-Q · filed 2019-05-17 |